Heart Test Laboratories, Inc. (HSCS)

NASDAQ: HSCS · IEX Real-Time Price · USD
5.42
-0.21 (-3.73%)
At close: May 22, 2024, 4:00 PM
5.60
+0.18 (3.32%)
After-hours: May 22, 2024, 7:57 PM EDT
-3.73%
Market Cap 3.55M
Revenue (ttm) 18,600
Net Income (ttm) -6.39M
Shares Out 655.62K
EPS (ttm) -48.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 96,956
Open 5.51
Previous Close 5.63
Day's Range 5.21 - 5.98
52-Week Range 5.21 - 128.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 14, 2024

About HSCS

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas. [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Jun 15, 2022
Employees 12
Stock Exchange NASDAQ
Ticker Symbol HSCS
Full Company Profile

Financial Performance

In 2023, HSCS's revenue was $5,150, a decrease of -64.17% compared to the previous year's $14,373. Losses were -$6.35 million, 31.6% more than in 2022.

Financial Statements

News

HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio

Southlake, Texas, May 20, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered m...

2 days ago - GlobeNewsWire

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

Patent covers use of AI-ECG for any echo measure of diastolic function, which is crucial for heart screening and early detection of heart disease Patent covers use of AI-ECG for any echo measure of di...

4 weeks ago - GlobeNewsWire

HeartSciences to Present at the LD Micro Invitational XIV Conference

Southlake, TX, April 02, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences  (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered m...

7 weeks ago - GlobeNewsWire

HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients

Data Demonstrated the Use of MyoVista wavECGTM for Screening Preoperative Patients for LVDD Can Be Recommended Data Demonstrated the Use of MyoVista wavECGTM for Screening Preoperative Patients for LV...

2 months ago - GlobeNewsWire

HeartSciences Reports Third Quarter Fiscal 2024 Financial Results

Southlake, TX, March 14, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered me...

2 months ago - GlobeNewsWire

HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes

Data Demonstrated MyoVista AI-ECG model significantly outperformed NT-proBNP and ARIC HF score, the conventional standards of care for Stage B Heart Failure screening Data Demonstrated MyoVista AI-ECG...

2 months ago - GlobeNewsWire

HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology

Southlake, TX, March 06, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered me...

2 months ago - GlobeNewsWire

HeartSciences Adds Key Advisor to its Scientific Advisory Board

Southlake, TX, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered med...

3 months ago - GlobeNewsWire

HeartSciences Expands its Scientific Advisory Board

Southlake, TX, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered med...

3 months ago - GlobeNewsWire

HeartSciences Appoints New Scientific Advisory Board Member

Southlake, TX, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered med...

3 months ago - GlobeNewsWire

HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting

Southlake, TX, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered med...

4 months ago - GlobeNewsWire

HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting

Southlake, TX, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"),  would like to remind its shareholders to v...

5 months ago - GlobeNewsWire

HeartSciences Reports Second Quarter Fiscal 2024 Financial Results

Southlake, TX, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered med...

5 months ago - GlobeNewsWire

HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway

Southlake, TX, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered med...

6 months ago - GlobeNewsWire

HeartSciences' MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police Officers

Southlake, Texas, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc.  d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an AI-powered medical technology compan...

6 months ago - GlobeNewsWire

Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Other symbols: ARQTBTTXEVLOSINT
7 months ago - Benzinga

HeartSciences Reports First Quarter Fiscal 2024 Financial Results

Southlake, TX, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based medi...

8 months ago - GlobeNewsWire

HeartSciences to Present at the Gilmartin Group Emerging Growth Showcase

Southlake, TX, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based medi...

9 months ago - GlobeNewsWire

HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence Awards

Southlake, TX, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based medi...

9 months ago - GlobeNewsWire

HeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, India

Southlake, TX, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc.  d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based med...

9 months ago - GlobeNewsWire

HeartSciences Signs Distribution Agreement with FJ Medical, Denmark

Southlake, TX, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc.  d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based medi...

9 months ago - GlobeNewsWire

HeartSciences' MyoVista® wavECGTM Selected to be used in Irish Heart Screening Evaluation

Southlake, TX, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc.  d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medi...

9 months ago - GlobeNewsWire

HeartSciences Announces Further Expansion of Artificial Intelligence (AI) Patent Portfolio

European Patent Allowed for Quantification by an ECG of Key Heart Measures using AI European Patent Allowed for Quantification by an ECG of Key Heart Measures using AI

9 months ago - GlobeNewsWire

MyoVista wavECG goes into clinical use at the Naya Imaging Center in Denmark

Southlake, Texas, July 27, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc.  d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based m...

10 months ago - GlobeNewsWire

HeartSciences Provides Business Update and Reports Fiscal 2023 Financial Results

Southlake, Texas, July 19, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc.  d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based m...

11 months ago - GlobeNewsWire